Atlas Trials

Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV

Clinical trial NCT02798692 · COMPLETED

Trial details

NCT number
NCT02798692
Sponsor
Hookipa Biotech GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cytomegalovirus Infection
Start date
2016-06-01
Primary completion
2017-05-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.